Features | Partner Sites | Information | LinkXpress
Sign In
Bio-Rad Diabetes Division
FOCUS DIAGNOSTICS, INC.
RANDOX LABORATORIES

Automated Decapping System Replaces Manual Steps

By Labmedica International staff writers
Posted on 17 Jan 2012
Image: The Decapper unit automates initial steps of sample processing, decapping, and aliquotting (Photo courtesy of Qiagen).
Image: The Decapper unit automates initial steps of sample processing, decapping, and aliquotting (Photo courtesy of Qiagen).
An open platform system enables laboratories to automate many tedious manual steps required for unscrewing (or “decapping”) the lids of clinical sample vials, extracting the sample material, and pipetting it into testing vials and then recapping the clinical sample vial.

The QIAensemble Decapper improves laboratory workflow by providing an automated solution for transferring clinical samples from closed primary vials to compatible tubes for downstream processing

Qiagen N.V. (Hilden, Germany) launched the QIAensemble Decapper automation system that will facilitate the handling of liquid-based cytology and various other types of liquid samples that are processed by clinical laboratories around the world.

Considered the first instrument of its kind designed to support downstream molecular testing, the QIAensemble Decapper will help to reduce the risk for injuries to laboratory staff from repetitive motions, while also eliminating the risk for variation among laboratory staff and improving productivity.

A professional ergonomics evaluation of the sample preparation processing of 88 samples showed QIAensemble Decapper reduced hands-on time by 70% compared to the time required for manual processing by a laboratory worker while eliminating more than 1,200 movements.

With a capacity to process up to approximately 800 samples per shift (excluding set-up time and post-processing requirements), QIAensemble Decapper was designed specifically for the handling and transfer of sample materials, and the addition of reagents. The instrument accommodates a variety of fluid types of variable viscosity for both samples and reagents.

The software system, which is operated by an intuitive graphical user interface (GUI), provides laboratory staff with a comprehensive and user-friendly report for each run. The software also offers chain of custody and an ability to identify samples that were not properly transferred.

The Decapper standardizes the processing with digital data collection and is highly flexible with regard to output tube types, such as conical tubes, u-shaped tubes, BD Vacutainer tubes, and Greiner’s Vacuette tubes. Additionally, the instrument will be compatible with sample racks on the QIAsymphony SP automation system.

Related Links:
Qiagen



PURITAN MEDICAL
77 ELEKTRONIKA
DiagCor Bioscience
comments powered by Disqus
Sekisui Diagnostics

Channels

Clinical Chemistry

view channel
Image: The Cobas 6000 Multipurpose Clinical Laboratory analyzer (Photo courtesy of Roche Diagnostics).

Low Density Lipoprotein Apolipoprotein-B Assay Validated

The relationship between apolipoprotein-B (Apo-B) concentration and the risk of developing cardiovascular disease (CVD) is more robust than the relationship between low density lipoprotein cholesterol... Read more

Genetic Tests

view channel
Histopathology of colonic adenocarcinoma; the glands are enlarged and filled with necrotic debris (Photo courtesy of the University of Utah).

Promising Blood Biomarkers Isolated for Colorectal Cancer

The search for blood-borne biomarkers that could be used to screen for colorectal cancer (CRC) has uncovered two promising candidates that may one day lead to the development of a simple blood test.... Read more

Microbiology

view channel

Novel Sequence Analysis Services Improve Pathogen Identification

A set of new-generation sequencing (NGS) services provides unique tools for more effective identification of known and unknown microorganisms, including bacterial, viral, fungal, and protozoan parasite pathogens. Aperiomics (Ashburn, VA, USA) has now introduced its breakthrough Absolute-NGS Pathogen Detection Platform... Read more

Industry News

view channel

Market for qPCR Exceeds USD 3 Billion

The market for real-time quantitative polymerase chain reaction (qPCR) was valued at about USD 3.2 billion for 2013 according to Kalorama Information (New York, NY, USA) an increase from USD 2.8 billion in 2011. The healthcare market researcher said that the testing system is considered the workhorse of research providing... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.